Hansoh Pharmaceutical Group Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Hansoh Pharmaceutical Group hat ein Gesamteigenkapital von CN¥25.8B und eine Gesamtverschuldung von CN¥4.2B, wodurch sich der Verschuldungsgrad auf 16.4% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen CN¥33.0B bzw. CN¥7.2B. Hansoh Pharmaceutical Group Das EBIT des Unternehmens beträgt CN¥2.7B, so dass der Zinsdeckungsgrad -2.8 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von CN¥24.9B.
Wichtige Informationen
0.1%
Verhältnis von Schulden zu Eigenkapital
CN¥40.26m
Verschuldung
| Zinsdeckungsgrad | -4.1x |
| Bargeld | CN¥23.50b |
| Eigenkapital | CN¥27.90b |
| Gesamtverbindlichkeiten | CN¥3.77b |
| Gesamtvermögen | CN¥31.67b |
Jüngste Berichte zur Finanzlage
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28Recent updates
Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Aug 28Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 43% Above Its Share Price
Nov 07Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Oct 11Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 3692Die kurzfristigen Aktiva des Unternehmens (CN¥28.9B) übersteigen seine kurzfristigen Passiva (CN¥6.9B).
Langfristige Verbindlichkeiten: 3692Die kurzfristigen Vermögenswerte des Unternehmens (CN¥28.9B) übersteigen seine langfristigen Verbindlichkeiten (CN¥381.5M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 3692 über mehr Barmittel verfügt als seine Gesamtverschuldung.
Schulden abbauen: 3692Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 0% auf 16.4% gestiegen.
Schuldendeckung: 3692Die Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (73.8%).
Zinsdeckung: 3692 mehr Zinsen einnimmt als er zahlt, so dass die Deckung der Zinszahlungen kein Problem darstellt.